GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (OTCPK:OXBOF) » Definitions » Forward PE Ratio

Oxford BioDynamics (Oxford BioDynamics) Forward PE Ratio : 0.00 (As of May. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Oxford BioDynamics Forward PE Ratio?

Oxford BioDynamics's Forward PE Ratio for today is 0.00.

Oxford BioDynamics's PE Ratio without NRI for today is 0.00.

Oxford BioDynamics's PE Ratio for today is 0.00.


Oxford BioDynamics Forward PE Ratio Historical Data

The historical data trend for Oxford BioDynamics's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Forward PE Ratio Chart

Oxford BioDynamics Annual Data
Trend
Forward PE Ratio

Oxford BioDynamics Semi-Annual Data
Forward PE Ratio

Competitive Comparison of Oxford BioDynamics's Forward PE Ratio

For the Biotechnology subindustry, Oxford BioDynamics's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioDynamics's Forward PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's Forward PE Ratio falls into.



Oxford BioDynamics Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Oxford BioDynamics  (OTCPK:OXBOF) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Oxford BioDynamics Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioDynamics (Oxford BioDynamics) Business Description

Traded in Other Exchanges
Address
Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.

Oxford BioDynamics (Oxford BioDynamics) Headlines

From GuruFocus